Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine sulfate for adult Henoch-Schonlein purpura nephritis
ChiCTR2200057905Phase 4Recruiting
- Sponsor
- Army Specialized Medical Center
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hydroxychloroquine in IgA vasculitis nephritis (2 arms), sponsored by Army Specialized Medical Center. Primary endpoints: Urinary protein change rate, 24-hour urinary protein and 1 more. Started Jun 2021; status: recruiting.
02
Drugs
hydroxychloroquine
03
Conditions
IgA vasculitis nephritis
Beyond the preview
Go deeper on ChiCTR2200057905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057905.